Document is current
Any future updates will be listed below
-
Authors
Banerjee, Rahul https://orcid.org/0000-0003-3781-5441
Biru, Yelak
Cole, Craig E. https://orcid.org/0000-0002-5537-761X
Faiman, Beth
Midha, Shonali
Ailawadhi, Sikander https://orcid.org/0000-0002-8377-8111
- License Information
-
More Information
Article History
Received: 26 May 2024
Revised: 12 August 2024
Accepted: 14 August 2024
First Online: 27 August 2024
Competing interests
: RB reports consulting: Adaptive Biotech, BMS, Caribou Biosciences, Genentech, GSK, Janssen, Karyopharm, Legend Biotech, Pfizer, Sanofi, SparkCures; research: Abbvie, BMS, Janssen, Novartis, Pack Health, Prothena, Sanofi. CEC reports consulting: AbbVie, Binding Site, Genentech, GSK, Janssen, Pfizer: research, GSK. BF reports consulting: BMS, GSK, Janssen, Karyopharm, Sanofi. SM reports consulting: Pfizer, stock ownership: AbbVie. SA reports consulting: BeiGene, BMS, Cellectar, GSK, Janssen, Pfizer, Regeneron, Sanofi, Takeda; research: AbbVie, Amgen, Ascentage, BMS, Cellectar, GSK, Janssen, Pharmacyclics, Sanofi. The remaining authors have no disclosures.
